Respiratory syncytial virus
RSV · Infectious Disease · 2 drugs · 2 indications
Respiratory virus infection, severe in infants and elderly.
Competitive Landscape (2 drugs)
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|
| Beyfortus | SOBI | — | Monoclonal antibody | IM | APPROVED |
| Enflonsia | MRK | Anti-RSV F protein monoclonal antibody | Monoclonal antibody | IM | APPROVED |
Indications (2)
RSV prevention in infants
Upcoming Catalysts
Beyfortus - RSV Royalty Revenue Trajectory (vs Enflonsia)COMMERCIAL
SOBIQuarterly through 2026
Data from Supabase · Updated 2026-03-24